The Impact of Prices and Distribution on Customer Satisfaction in the Pharmaceutical Industry of Kazakhstan

키워드

참고문헌 (58)

1. Afonso, O., "The impact of the health sector on R&D, economic growth, and wages", Applied Economics Letters, 23(14), pp.1006~1011 (2016)[DOI]
2. Albahar, A., "How AI Improves Telemedicine through Improving Data Management in Healthcare", Journal of Knowledge Learning and Science Technology, 2, pp.242~250 (2023)[DOI]
3. Almomani, H. Q., "Why Do People Buy Prescription Medicines Online? A Qualitative Interview Study", International Journal of Pharmacy Practice, 31(1), pp.112~113 (2023)[DOI]
4. Amangeldin, M., "Structure analysis of the worldwide pharmaceutical market and prospects for its development in Kazakhstan", European Journal of Entomology, 4, pp.14~22 (2017)[DOI]
5. Apan, R. D., "Advertising of Medicines for Human Use. Perspectives from European Court of Justice", International Journal of Legal and Social Order, 1(1), pp.491~500 (2021)[DOI]
6. Bahremand, M., "A Multi-Objective Pricing Model in Omnichannel Retailing with Emphasis on State Interventions", IEEE Access, 10, pp.1~14 (2022)[DOI]
7. Becker, M. C., "Marketing", R&D integration in the pharmaceutical industry, 2006, pp.35(1), 105~120
8. Biswas, K., "Influence of Pharmaceutical Marketing on Prescription Behavior of Physicians : A Cross-sectional Study in Bangladesh", Journal of Accounting & Marketing, 5, pp.1~4 (2016)[DOI]
9. Boshoff, C., "The relationships between service quality, customer satisfaction and buying intentions in the private hospital industry", South African Journal of Business Management, 35, pp.27~38 (2004)[DOI]
10. "Annual statistical collections of the Republic of Kazakhstan" (2023)[URL]
11. Burinskiene, A., "Forecasting Model : The Case of the Pharmaceutical Retail", Frontiers in Medicine, 9, pp.1~16 (2022)[DOI]
12. Candan, G., "Demand forecasting in pharmaceutical industry using neuro-fuzzy approach", Journal of Management and Information Science, 2(2), pp.41~49 (2014)[DOI]
13. Chen, J., "The impact of customer returns on pricing and order decisions", European Journal of Operational Research, 195(1), pp.280~295 (2009)[DOI]
14. Chornous, G., "Marketing mix modeling for pharmaceutical companies on the basis of data science technologies", Access Journal - Access to Science, Business, Innovation in the digital economy, 2(3), pp.274~289 (2021)[DOI]
15. Corden, K., "A Systematic Review of Healthcare Professionals' Knowledge, Self-Efficacy and Attitudes Towards Working with Autistic People", Review Journal of Autism and Developmental Disorders, 9(3), pp.386~399 (2022)[DOI]
16. Digel, I. E., "Evaluating development prospects of smart cities : Cluster analysis of Kazakhstan's regions", Problems and Perspectives in Management, 20(4), pp.76~86 (2022)[DOI]
17. Do Yeon, K., "How Does Medical Expenditure Affect Economic Development? Evidence from OECD countries", The International Review of Financial Consumers, 4(1), pp.39~49 (2019)[DOI]
18. Lee, K., "Combating Sale of Counterfeit and Falsified Medicines Online : A Losing Battle", Frontiers in Pharmacology, 8, pp.286~290 (2017)[DOI]
19. Ensor, T., "Health economics in low income countries : adapting to the reality of the unofficial economy", Health Policy, 57(1), pp.1~13 (2001)[DOI]
20. Faruk, B., "The association between health expenditure, institutions, and economic growth in MENA countries", Health Promotion Perspectives, 12(1), pp.92~100 (2022)[DOI]
21. Freitas, M., "The influence of the healthcare system on optimal economic growth", Economic Modelling, 35, pp.734~742 (2013)[DOI]
22. Jack, W., "Health investments and economic growth : Macroeconomic evidence and microeconomic foundations", World Bank, ~ (2009)
23. Jackson, G., "Assessing the problem of counterfeit medications in the United Kingdom", International Journal of Clinical Practice, 66(3), pp.241~250 (2012)[DOI]
24. Jagric, T., "What drives the healthcare sector's economic impact? Evidence from European countries", International Journal of Health Governance, 27(1), pp.41~53 (2021)[DOI]
25. Jaric, T., "Toward an economy of wellbeing : The economic impact of the Welsh healthcare sector", Frontiers in Public Health, 10, pp.953752~ (2022)[DOI]
26. Jia, J., "Dynamic ordering and pricing for a perishable goods supply chain", Computers & Industrial Engineering, 60(2), pp.302~309 (2011)[DOI]
27. Johnson, J., "Levels of analysis and sources of data in sales research : a multilevel-multisource review", Journal of Personal Selling & Sales Management, 34(1), pp.70~86 (2014)[DOI]
28. Kalandarishvili, N, "Healthcare Technologies and Big Data", Business Administration Research Papers, 8(2), pp.1~5 (2023)[DOI]
29. Kalayou, M. H., "Physicians' Attitude Towards Electronic Medical Record Systems : An Input For Future Implementers", Biomed Research International, 1, pp.9~21 (2021)[DOI]
30. Kim, W., "Demand Forecasting Models for Medicines through Wireless Sensor Networks Data and Topic Trend Analysis", International Journal of Distributed Sensor Networks, 11(9), pp.1~6 (2015)[DOI]
31. Philipsen, N. J., "Regulation of pharmacists : a comparative law and economics analysis", The European journal of comparative economics, 10(2), pp.225~241 (2013)[DOI]
32. Koikov, V., "Improving the system continuous professional development of the health workers", European Journal of Public Health, 30(5), pp.166~644 (2020)[DOI]
33. Latta, M., "How to Forecast the Demand of a New Drug in the Pharmaceutical Industry", Journal of Business Forecasting, 26, pp.21~28 (2007)
34. Lavorgna, A., "The online trade in counterfeit pharmaceuticals : New criminal opportunities, trends and challenges", European Journal of Criminology, 12(2), pp.226~241 (2015)[DOI]
35. Lawate, M., "Pharmaceutical Sales and Marketing", International Journal of Advanced Research in Science, Communication and Technology, 3(1), pp.606~615 (2023)[DOI]
36. Mahdaoui, M., "Morocco's Healthcare System: Achievements, Challenges, and Perspectives", Cureus, 15(6), pp.e41143~ (2023)[DOI]
37. Maihami, R., "Optimizing the pricing and replenishment policy for non-instantaneous deteriorating items with stochastic demand and promotional efforts", Computers & Operations Research, 51, pp.302~312 (2014)[DOI]
38. Miao, R., "Using structural equation modeling to analyze patient value, satisfaction, and loyalty : a case study of healthcare in China", International Journal of Production Research, 58, pp.577~596 (2019)[DOI]
39. Mash, R., "The roles and training of primary care doctors : China, India, Brazil and South Africa", Human Resources for Health, 13, pp.1~9 (2015)[DOI]
40. Mendoza, R. L., "Internet medicine and pharmacies : Private choice, public risks, and healthcare business", International Journal of Healthcare Management, 7, pp.185~199 (2014)[DOI]
41. Mousa, B., "Predicting medicine demand using deep learning techniques : Areview", Journal of Intelligent Systems, 32(1), pp.1~16 (2023)[DOI]
42. Newton, P., "Counterfeit anti-infective drugs", The Lancet. Infectious diseases, 6(9), pp.602~613 (2006)[DOI]
43. Nick, M., "An intelligent algorithm for final product demand forecasting in pharmaceutical units", International Journal of System Assurance Engineering and Management, 11(2), pp.481~493 (2020)[DOI]
44. Nunez Cabrera, E., "Self-Efficacy of the Community Health Agent, Importance of Motivation and Empowerment", Journal of Primary Care & Community Health, 14, pp.1~10 (2023)[DOI]
45. O'Hagan, A., "Counterfeit drugs and the online pharmaceutical trade, a threat to public safety", Forensic Research & Criminology International Journal, 6(3), pp.151~158 (2018)[DOI]
46. Okolie, U., "Health Expenditure and Nigeria's Economic Growth", Jurnal Pendidikan Ilmu Sosial, 12(1), pp.92~100 (2023)[DOI]
47. Olbrich, R., "Effects of pricing strategies and product quality on private label and national brand performance", Journal of Retailing and Consumer Services, 34, pp.294~301 (2017)[DOI]
48. Panda, S. K., "Drug traceability and transparency in medical supply chain using blockchain for easing the process and creating trust between stakeholders and consumers", Personal and Ubiquitous Computing, 28, pp.75~91 (2021)[DOI]
49. Rad, M., "Optimal production and distribution policies for a two-stage supply chain with imperfect items and price-and advertisement-sensitive demand : A note", Applied Mathematical Modelling, 57, pp.625~632 (2016)[DOI]
50. Rudenko, E., "Marketing projects of the pharmaceutical industry. Analysis and feature", Management of Development of Complex Systems, 54, pp.40~47 (2023)[DOI]
51. Soni, H., "Optimal pricing and replenishment policy for non-instantaneous deteriorating items with varying rate of demand and partial backlogging", OPSEARCH, pp.1~36 (2020)[DOI]
52. Stros, M., "Marketing dimensions in the prescription pharmaceutical industry : a systematic literature review", Journal of Strategic Marketing, 23(4), pp.318~336 (2015)[DOI]
53. Szabo-Geletoczki, R., "Market Changes in the Pharmaceutical Industry", Acta Universitatis Sapientiae, European and Regional Studies, 22(1), pp.50~72 (2022)[DOI]
54. Seidman, G., "What benefits do healthcare organisations receive from leadership and management development programmes? A systematic review of the evidence", BMJ Leader, 4, pp.21~36 (2020)[DOI]
55. Ward, R., "The attitudes of health care staff to information technology : a comprehensive review of the research literature", Health information and libraries journal, 25(2), pp.81~97 (2008)[DOI]
56. Zhakipbekov, K., "Analysis of the current state of the pharmaceutical market of the Republic of Kazakhstan", ScienceRise : Pharmaceutical Science, 2(42), pp.57~67 (2023)[DOI]
57. Zhang, J., "Joint optimization on pricing, promotion and inventory control with stochastic demand", International Journal of Production Economics, 116(2), pp.190~198 (2008)[DOI]
58. Zhu, X., "Demand forecasting with supply-chain information and machine learning : Evidence in the pharmaceutical industry", Production and Operations Management, 30(9), pp.3231~3252 (2021)[DOI]

관련 논문AI추천